Drugs precisely delivered by suprachoroidal injection with access to the choroid and the retina where the diseases present. 
Drugs will be most effective if they can be delivered directly to the part of the eye that requires treatment, such as the choroid and retina”
Eye diseases such as uveitis and diabetic macular edema present in the choroid and retina. Through the ingenious efforts of our research and development team, we have developed a unique and elegant way to access the choroid and retina through the suprachoroidal space to treat these diseases.
 Improved benefits to risk ratio
CLS-is administered by suprachoroidal injection.
Not available for clinical use. Not approved by the or other regulatory bodies.
Learn more about career opportunities and benefits at Biomedical.
We see a world without blindness.
The pursuit of transformative, elegant, precise solutions to restore and preserve vision.
Our core values of leadership, achievement, teamwork, integrity, and communication ground us in our pursuit.
General Counsel and Chief Compliance Officer
Chairperson, Executive Vice President of Ortho Dermatologic
Board Member, Venture Partner and Managing Director of Hatteras Discovery
Board Member, General Partner with Hatteras Venture Partners 
Learn more about career opportunities and benefits at Biomedical.
